EPRSQ — Epirus Biopharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Epirus Biopharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2011 December 31st	C2012 December 31st	R2013 December 31st	R2014 December 31st	2015 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-Q	10-Q	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	47.9	34.6	1.8	21.5	31.5
Net Total Accounts Receivable
Net Total Receivables	1.89	3.04	—	0.004	0.13
Prepaid Expenses
Total Other Current Assets
Total Current Assets	51.2	38.4	2.69	23	35.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5.26	3.54	0.09	0.704	2.07
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	79.9	61.4	6.79	51.4	72.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15.5	19.6	16.2	7.38	33.3
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	36	30.3	46.2	19	35.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	43.9	31	-39.4	32.4	36.4
Total Liabilities & Shareholders' Equity	79.9	61.4	6.79	51.4	72.3
Total Common Shares Outstanding